Emergent BioSolutions Inc. SEC filings EBS
Emergent BioSolutions Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 29, 2014. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 16, 2026 |
| 144 | Notice of proposed sale | Oct 7, 2026 | — |
| 4 | Insider transaction | Oct 7, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Aug 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 3 | Initial insider ownership | Aug 12, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 28, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 29, 2026 |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| 10-Q | Quarterly report | May 1, 2026 | Mar 31, 2026 |
| S-8 | Employee stock plan registration | Apr 30, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 30, 2026 | Apr 30, 2026 |
| 144 | Notice of proposed sale | Apr 30, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Apr 30, 2026 | Apr 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Apr 17, 2026 | Apr 16, 2026 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 9, 2026 | — |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 144 | Notice of proposed sale | Apr 1, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| ARS | Annual report to shareholders | Mar 20, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 20, 2026 | — |
| DEF 14A | Proxy statement | Mar 20, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 6, 2026 | May 7, 2025 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 3 | Initial insider ownership | Mar 5, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 3, 2026 | Feb 25, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 144 | Notice of proposed sale | Jan 7, 2026 | — |
| 144 | Notice of proposed sale | Dec 22, 2025 | — |
| 4 | Insider transaction | Dec 16, 2025 | Dec 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 144 | Notice of proposed sale | Dec 5, 2025 | — |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 144 | Notice of proposed sale | Nov 10, 2025 | — |
| 144 | Notice of proposed sale | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 16, 2025 | Oct 7, 2025 |
| 144 | Notice of proposed sale | Oct 7, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 11, 2025 | Sep 5, 2025 |
| 8-K |
Current report
Other events
|
Sep 5, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 15, 2025 |
| EFFECT | Filing | Aug 15, 2025 | — |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 12, 2025 |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| S-3 | Shelf registration | Aug 7, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2025 | Aug 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 23, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 8, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 8, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 8, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 8, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 8-K |
Current report
Other events
|
May 23, 2025 | May 23, 2025 |
| 144 | Notice of proposed sale | May 23, 2025 | — |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 6, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 9, 2025 | Apr 7, 2025 |
| 4 | Insider transaction | Apr 9, 2025 | Apr 7, 2025 |
| 4/A | Form 4/a | Apr 9, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Other events
|
Mar 31, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Mar 24, 2025 | — |
| 424B3 | Prospectus | Mar 24, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 24, 2025 | Mar 19, 2025 |
| DEF 14A | Proxy statement | Mar 21, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 21, 2025 | — |
| ARS | Annual report to shareholders | Mar 21, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 12, 2025 |
| 144 | Notice of proposed sale | Mar 12, 2025 | — |
| 144 | Notice of proposed sale | Mar 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| POS AM | Filing | Mar 4, 2025 | — |
| POS EX | Filing | Mar 4, 2025 | — |
| 424B3 | Prospectus | Mar 4, 2025 | — |
| 4 | Insider transaction | Mar 4, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 12, 2025 |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 3, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Other events
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Other events
|
Jan 8, 2025 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 15, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 8, 2024 |
| EFFECT | Filing | Dec 4, 2024 | — |
| 424B3 | Prospectus | Dec 4, 2024 | — |
| CORRESP | Letter to the SEC | Dec 2, 2024 | — |
| S-1/A | Amended registration statement | Dec 2, 2024 | — |
| 3 | Initial insider ownership | Nov 21, 2024 | Nov 18, 2024 |
| UPLOAD | Letter from the SEC | Nov 18, 2024 | — |
| 4 | Insider transaction | Nov 14, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 13, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| 3 | Initial insider ownership | Nov 12, 2024 | Oct 29, 2024 |
| S-1 | Registration statement | Nov 12, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure
|
Oct 2, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Sep 17, 2024 | Sep 17, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 10, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Sep 3, 2024 | Aug 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 30, 2024 | Aug 29, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EBS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- Accelerated filer
- SEC CIK
- 1367644
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.